Average Co-Inventor Count = 7.83
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Frosst Canada & Co. (4 from 76 patents)
2. Merck Canada Inc. (2 from 40 patents)
3. Merck Sharp + Dohme Corp. (1 from 2,405 patents)
4. Actelion Pharmaceuticals Ltd (1 from 217 patents)
5. Merck Frosst Canada, Inc. (1 from 212 patents)
6. Merck Forsst Canada & Co. (1 from 1 patent)
7. Idorsia Pharmaceuticals Ltd (77 patents)
10 patents:
1. 8889714 - 3,4-substituted piperidine derivatives as renin inhibitors
2. 8343968 - Case of renin inhibitors
3. 8076359 - Renin inhibitors
4. 7960409 - Pharmaceutical phenylquinoline and chromen-2-one triazole compounds
5. 7553973 - Pharmaceutical compounds
6. 7439260 - 7-(1,3-thiazol-2-YL)thio-coumarin derivatives and their use as leukotriene biosynthesis inhibitors
7. 6841564 - Tri-aryl-substituted-ethane PDE4 inhibitors
8. 6743802 - Alkyne-aryl phosphodiesterase-4 inhibitors
9. 6677351 - 1-biaryl-1,8-naphthyridin-4-one phosphodiesterase-4 inhibitors
10. 6399636 - Tri-aryl-substituted-ethane PDE4 inhibitors